LUBIPROSTONE
Generic: LUBIPROSTONE
Camber PharmaceuticalsManufacturer
ORALRoute
LUBIPROSTONEActive Substance
2025-01-02Original Approval
LUBIPROSTONE is FDA application ANDA218640, sponsored by ASCENT PHARMS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
NAUSEA
100 reports
2
CONSTIPATION
76 reports
3
FATIGUE
72 reports
4
OFF LABEL USE
65 reports
5
DIARRHOEA
62 reports
6
DIZZINESS
62 reports
7
DRUG INEFFECTIVE
62 reports
8
HEADACHE
53 reports
9
DYSPNOEA
51 reports
10
VOMITING
48 reports